Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Atypical diagnosis for typical lung carcinoid.

Piro R, Tonelli R, Taddei S, Marchioni A, Musci G, Clini E, Facciolongo N.

BMC Pulm Med. 2019 Sep 2;19(1):168. doi: 10.1186/s12890-019-0929-0.

2.

A case of chronic eosinophilic pneumonia in a patient treated with dupilumab.

Menzella F, Montanari G, Patricelli G, Cavazza A, Galeone C, Ruggiero P, Bagnasco D, Facciolongo N.

Ther Clin Risk Manag. 2019 Jul 10;15:869-875. doi: 10.2147/TCRM.S207402. eCollection 2019.

3.

Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?

Menzella F, Biava M, Bagnasco D, Galeone C, Simonazzi A, Ruggiero P, Facciolongo N.

Drugs Context. 2019 Apr 15;8:212580. doi: 10.7573/dic.212580. eCollection 2019. Review.

4.

European consensus meeting/statement on Bronchial Thermoplasty Who? Where? How?

Niven R, Aubier M, Bonta P, Puente-Maestu L, Facciolongo N, Ryan D.

Respir Med. 2019 Apr;150:161-164. doi: 10.1016/j.rmed.2019.02.020. Epub 2019 Mar 22.

PMID:
30961945
5.

Thoracic Hyper-IgG4-Related Disease Mimicking Malignant Pleural Mesothelioma.

Lococo F, Di Stefano T, Rapicetta C, Piro R, Gelli MC, Muratore F, Ricchetti T, Taddei S, Zizzo M, Cesario A, Facciolongo N, Paci M.

Lung. 2019 Jun;197(3):387-390. doi: 10.1007/s00408-019-00224-5. Epub 2019 Apr 2.

PMID:
30941506
6.

Competence in bronchial thermoplasty.

Facciolongo N, Polese G, Romani S, Corbetta L.

Panminerva Med. 2019 Sep;61(3):422-428. doi: 10.23736/S0031-0808.18.03582-6. Epub 2018 Nov 27.

7.

Acute respiratory failure as presentation of late-onset Pompe disease complicating the diagnostic process as a labyrinth: a case report.

Menzella F, Codeluppi L, Lusuardi M, Galeone C, Valzania F, Facciolongo N.

Multidiscip Respir Med. 2018 Sep 1;13:32. doi: 10.1186/s40248-018-0145-4. eCollection 2018.

8.

Precision Medicine in Targeted Therapies for Severe Asthma: Is There Any Place for "Omics" Technology?

Galeone C, Scelfo C, Bertolini F, Caminati M, Ruggiero P, Facciolongo N, Menzella F.

Biomed Res Int. 2018 Jun 11;2018:4617565. doi: 10.1155/2018/4617565. eCollection 2018. Review.

9.

Heat-induced necrosis after bronchial thermoplasty: a new concern?

Menzella F, Lusuardi M, Galeone C, Montanari G, Cavazza A, Facciolongo N.

Allergy Asthma Clin Immunol. 2018 Jun 25;14:25. doi: 10.1186/s13223-018-0252-y. eCollection 2018.

10.

Towards precision medicine: The application of omics technologies in asthma management.

Scelfo C, Galeone C, Bertolini F, Caminati M, Ruggiero P, Facciolongo N, Menzella F.

Version 2. F1000Res. 2018 Apr 4 [revised 2018 Jan 1];7:423. doi: 10.12688/f1000research.14309.2. eCollection 2018.

11.

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma.

Facciolongo N, Di Stefano A, Pietrini V, Galeone C, Bellanova F, Menzella F, Scichilone N, Piro R, Bajocchi GL, Balbi B, Agostini L, Salsi PP, Formisano D, Lusuardi M.

BMC Pulm Med. 2018 Feb 8;18(1):29. doi: 10.1186/s12890-017-0554-8.

12.

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty.

Menzella F, Galeone C, Lusuardi M, Simonazzi A, Castagnetti C, Ruggiero P, Facciolongo N.

Ther Clin Risk Manag. 2017 Nov 8;13:1489-1493. doi: 10.2147/TCRM.S149775. eCollection 2017.

13.

Bronchial thermoplasty and the role of airway smooth muscle: are we on the right direction?

Menzella F, Lusuardi M, Galeone C, Facciolongo N.

Ther Clin Risk Manag. 2017 Sep 19;13:1213-1221. doi: 10.2147/TCRM.S144604. eCollection 2017. Review.

14.

Endobronchial ultrasound-guided transbronchial needle aspiration under conscious sedation with meperidine and midazolam.

Agostini L, Facciolongo N, Lusuardi M, Casalini E, Galeone C, Lasagni L, Zucchi L.

Monaldi Arch Chest Dis. 2017 Jul 18;87(2):768. doi: 10.4081/monaldi.2017.768.

15.

Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?

Menzella F, Galeone C, Bertolini F, Castagnetti C, Facciolongo N.

J Asthma Allergy. 2017 Aug 30;10:237-247. doi: 10.2147/JAA.S144100. eCollection 2017. Review.

16.

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.

Menzella F, Lusuardi M, Galeone C, Taddei S, Facciolongo N, Zucchi L.

Ther Adv Chronic Dis. 2016 Nov;7(6):260-277. Epub 2016 Aug 11. Review.

17.

How Effective and Safe Is Bronchial Thermoplasty in "Real Life" Asthmatics Compared to Those Enrolled in Randomized Clinical Trials?

Arrigo R, Failla G, Scichilone N, La Sala A, Galeone C, Battaglia S, Benfante A, Facciolongo N.

Biomed Res Int. 2016;2016:9132198. Epub 2016 Sep 8.

18.

The clinical profile of benralizumab in the management of severe eosinophilic asthma.

Menzella F, Lusuardi M, Galeone C, Facciolongo N, Zucchi L.

Ther Adv Respir Dis. 2016 Dec;10(6):534-548. Epub 2016 Sep 9. Review.

19.

Clinical usefulness of mepolizumab in severe eosinophilic asthma.

Menzella F, Lusuardi M, Montanari G, Galeone C, Facciolongo N, Zucchi L.

Ther Clin Risk Manag. 2016 Jun 8;12:907-16. doi: 10.2147/TCRM.S86299. eCollection 2016. Review.

20.

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report.

Facciolongo N, Menzella F, Lusuardi M, Piro R, Galeone C, Castagnetti C, Cavazza A, Carbonelli C, Zucchi L, Salsi PP.

Multidiscip Respir Med. 2015 Mar 8;10(1):9. doi: 10.1186/s40248-015-0002-7. eCollection 2015.

21.

A budget impact analysis of bronchial thermoplasty for severe asthma in clinical practice.

Menzella F, Zucchi L, Piro R, Galeone C, Castagnetti C, Facciolongo N.

Adv Ther. 2014 Jul;31(7):751-61. doi: 10.1007/s12325-014-0135-7. Epub 2014 Jul 10.

PMID:
25009004
22.

Training and practice in bronchoscopy a national survey in Italy.

Facciolongo N, Piro R, Menzella F, Lusuardi M, Salio M, Agli LL, Patelli M.

Monaldi Arch Chest Dis. 2013 Sep-Dec;79(3-4):128-33.

23.

"Neurologist's contribution to the diagnosis of sine materia respiratory insufficiency: case report".

Carbonelli C, Zedde M, Cavazza A, Facciolongo N, Menzella F, Spaggiari L, Zucchi L.

BMC Pulm Med. 2012 Aug 8;12:42. doi: 10.1186/1471-2466-12-42.

24.

Acute respiratory distress syndrome: an undercover antisynthetase syndrome: a case report and a review of the literature.

Bajocchi G, Piro R, Lombardini C, Cavazza A, Facciolongo N.

Clin Exp Rheumatol. 2012 May-Jun;30(3):424-8. Epub 2012 Jun 26. Review.

PMID:
22704642
25.

Clinical audit on diagnostic accuracy and management of respiratory failure in COPD.

Menzella F, Facciolongo N, Lusuardi M, Piro R, Formisano D, Castagnetti C, Simonazzi A, Zucchi L.

Respir Care. 2012 Dec;57(12):2067-73. doi: 10.4187/respcare.01502.

26.

Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.

Menzella F, Facciolongo N, Piro R, Formisano D, Roggeri A, Simonazzi A, Castagnetti C, Carbonelli C, Zucchi L.

Ther Adv Respir Dis. 2012 Apr;6(2):87-95. doi: 10.1177/1753465811429478. Epub 2012 Feb 9.

PMID:
22323442
27.

Contraindications, risks, complications in interventional pneumology.

Facciolongo N.

Monaldi Arch Chest Dis. 2011 Mar;75(1):54-9. No abstract available.

28.

Long-term benefits of omalizumab in a patient with severe non-allergic asthma.

Menzella F, Piro R, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L.

Allergy Asthma Clin Immunol. 2011 May 24;7(1):9. doi: 10.1186/1710-1492-7-9.

29.

Eosinophilic infiltrate in a patient with severe Legionella pneumonia as a levofloxacin-related complication: a case report.

Facciolongo N, Menzella F, Castagnetti C, Cavazza A, Piro R, Carbonelli C, Zucchi L.

J Med Case Rep. 2010 Nov 11;4:360. doi: 10.1186/1752-1947-4-360.

30.

Omalizumab: when the non-responder is a late-responder.

Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L.

Eur Ann Allergy Clin Immunol. 2009 Oct;41(5):155-9.

PMID:
20101930
31.

Incidence of complications in bronchoscopy. Multicentre prospective study of 20,986 bronchoscopies.

Facciolongo N, Patelli M, Gasparini S, Lazzari Agli L, Salio M, Simonassi C, Del Prato B, Zanoni P.

Monaldi Arch Chest Dis. 2009 Mar;71(1):8-14.

PMID:
19522159
32.

Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.

Rossi G, Cavazza A, Marchioni A, Longo L, Migaldi M, Sartori G, Bigiani N, Schirosi L, Casali C, Morandi U, Facciolongo N, Maiorana A, Bavieri M, Fabbri LM, Brambilla E.

J Clin Oncol. 2005 Dec 1;23(34):8774-85.

PMID:
16314638
33.

Kit expression in small cell carcinomas of the lung: effects of chemotherapy.

Rossi G, Cavazza A, Marchioni A, Migaldi M, Bavieri M, Facciolongo N, Petruzzelli S, Longo L, Tamberi S, Crinò L.

Mod Pathol. 2003 Oct;16(10):1041-7.

34.

[Round atelectasis of the lung: clinicopathological study of 6 cases and review of the literature].

Cavazza A, Roggeri A, Rossi G, Carbonelli C, Falco F, Facciolongo N, Zucchi L.

Pathologica. 2003 Feb;95(1):50-6. Review. Italian.

PMID:
12735286
35.

Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.

Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, Maiorana A, Brambilla E.

Am J Surg Pathol. 2003 Mar;27(3):311-24.

PMID:
12604887
36.

[Small-cell mesothelioma of the pleura: description of a case].

Cavazza A, Rossi G, Agostini L, Facciolongo N, De Marco L, Putrino I, Gardini G.

Pathologica. 2002 Oct;94(5):247-52. Italian.

PMID:
12417972
37.

[Pulmonary metastasis of epidermoid carcinoma of the larynx: a case with an interstitial pattern of growth].

Cavazza A, Facciolongo N, De Marco L, Piana S, Putrino I, Gardini G.

Pathologica. 2002 Jun;94(3):136-41. Italian.

PMID:
12108034
38.

[Localization of hydatid cysts in the left hemidiaphragm. Description of a case].

Cattelani L, D'Ippolito R, Facciolongo N, Soliani P.

Acta Biomed Ateneo Parmense. 1988;59(1-2):41-7. Italian.

PMID:
2975130
39.

The flexible fiberoptic bronchoscopy and the aspiration lung biopsies in the diagnosis of the peripheral pulmonary carcinomas.

Marangio E, Pesci A, Gabrielli M, Consigli GF, Savini M, Casalini A, Facciolongo N.

Panminerva Med. 1986 Jul-Sep;28(3):227-8. No abstract available.

PMID:
3797037

Supplemental Content

Loading ...
Support Center